Brain scan dress rehearsal: setting the stage for future Parkinson's and paralysis trials
NCT ID NCT05698810
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is a practice run to see how well different brain and heart scans (MEG, MRI, EEG, ECG) work in healthy volunteers, people with Parkinson's disease, and those with paralysis. Researchers want to make sure the equipment and procedures are ready for larger future studies. About 150 participants will undergo these scans to help design better clinical trials down the road.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study will help design better future clinical trials for Parkinson's disease and paralysis by ensuring the equipment and procedures work smoothly.
- What could go wrong
- This is a very early feasibility study, not testing any treatment. It only checks if the equipment and methods are practical, so there is no direct benefit to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2023
- Expected to finish
-
Mar 2033
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ⩾ 18 years * Affiliated to a social security scheme * Free and informed consent signed Exclusion Criteria: * Subject in a period of exclusion from another study. * Subject deprived of liberty by a judicial or administrative decision, or major subject subject to a legal protection measure (guardianship, curatorship and safeguarding of justice) referred to in Articles 1121-6 to 1121-8 of the Public Health Code. * Subject who would receive more than 4500 euros in compensation because of his participation in other research involving the human person in the 12 months preceding this study. * Pregnant woman, parturient, nursing mother (Article 1121-5 of the Public Health Code) * Subject not reachable urgently.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy volunteers are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Clinatec Cea/Chuga
RECRUITINGGrenoble, 38000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New sedative candidate goes Head-to-Head with propofol in early human test
- Can a Room-Temperature dairy drink build muscle?
- New injection MWN117 tested for safety in obesity
- Can a new drug avoid the high? soticlestat put to the test
- Liver trouble changes how drugs work: scientists test soticlestat
- Can a hard cycling sprint change a Heart-Calming peptide?